Short Interest in Alterity Therapeutics Limited Rises By 684.6
| ATHE Stock | USD 3.34 0.38 10.22% |
About 61% of Alterity Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Alterity Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Alterity Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Alterity Therapeutics stock news signals to limit their universe of possible portfolio assets.
Alterity |
Alterity Therapeutics Limited was the recipient of a significant growth in short interest during the month of November. As of November 30th, there was short interest totalling 51,000 shares, a growth of 684.6 percent from the November 15th total of 6,500 shares. Based on an average daily volume of 571,200 shares,
Read at thelincolnianonline.com
 |
Alterity Therapeutics Fundamental Analysis
We analyze Alterity Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alterity Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alterity Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
Alterity Therapeutics is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
Alterity Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alterity Therapeutics stock to make a market-neutral strategy. Peer analysis of Alterity Therapeutics could also be used in its relative valuation, which is a method of valuing Alterity Therapeutics by comparing valuation metrics with similar companies.
Peers
Alterity Therapeutics Related Equities
| ARTL | Artelo Biosciences | 1.74 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.61 | ||||
| SRZN | Surrozen | 1.08 | ||||
| TARA | Protara Therapeutics | 1.17 | ||||
| PMVP | Pmv Pharmaceuticals | 1.95 | ||||
| HCWB | HCW Biologics | 2.44 | ||||
| MNPR | Monopar Therapeutics | 2.78 | ||||
| NBY | NovaBay Pharmaceuticals | 3.03 | ||||
| ANTX | AN2 Therapeutics | 3.70 | ||||
| ATXI | Avenue Therapeutics | 4.62 | ||||
| ADIL | Adial Pharmaceuticals | 4.67 | ||||
| RNAZ | Transcode Therapeutics | 4.99 | ||||
| QNRX | Quoin Pharmaceuticals | 6.06 | ||||
| RVPH | Reviva Pharmaceuticals | 6.50 | ||||
| ADTX | Aditxt | 10.53 |
Complementary Tools for Alterity Stock analysis
When running Alterity Therapeutics' price analysis, check to measure Alterity Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alterity Therapeutics is operating at the current time. Most of Alterity Therapeutics' value examination focuses on studying past and present price action to predict the probability of Alterity Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alterity Therapeutics' price. Additionally, you may evaluate how the addition of Alterity Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |